The Pfizer Pledge: Getting to 60% Remote Clinical Trials Across all Therapeutics Areas

Daniela Graham (Dani), MD, is a trained pediatrician who has been doing clinical research/development in the inflammation and immunization space for over 12 years. Dr Graham has broad experience in regulatory submissions and advisory committees enabling successful interactions and effective communication with regulators. Dr Graham is currently working as a Global Clinical Lead in the Inflammation and Immunology therapeutic area for Pfizer.Dr Graham was raised by two practicing physicians and knew from an early age that she wanted to pursue a career in medicine. Her desire to improve patient outcomes and positively impact multiple lives is a driving passion for her and gives her purpose. Working for Pfizer fuels her passion and purpose and as a leader in the organization,Dr Graham she is able to influence and inspire people internally.Dr Graham is a mom of two children and loves spending time with them. Additionally, Dr Graham enjoys hiking with her dogs, the beach and developing delicious creations in her kitchen.

Timothy Joy is the Head, Clinical Operations Strategic Solutions at Pfizer. Mr Joy is responsible for leading a global team tasked to identify and develop creative, scalable, technical and process related solutions for unmet global clinical trial needs.Mr Joy has been at Pfizer since 2001, when he joined Development Informatics. In Development Informatics he was responsible for implementation and support of Pfizer Electronic Data Capture systems. Since joining Global Product Development in 2006 Mr Joy has held multiple positions with increasing responsibility. He represented Pfizer on an Industry council to redesign and implement enhanced versions of Electronic Data Capture, implement clinical and operational data warehouse, and most recently developing Pfizer’s Decentralized Clinical Trial strategy.Mr Joy has been involved in numerous innovative projects and initiatives to redesign Investigator Site Support, implementation and usage of novel Patient Technologies, and creation of Pfizer’s eSource strategy.